Aarti Drugs (NSE:AARTIDRUGS) Construction In Progress: ₹2,138 Mil (As of Mar. 2026)


NSE:AARTIDRUGS Aarti Drugs Ltd NSE:AARTIDRUGS
73 GF Score
Price ₹388.95
GF Value ₹497.92
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Aarti Drugs Construction In Progress?

Aarti Drugs NSE:AARTIDRUGS +2.44% 73 Construction In Progress is ₹2,138 Mil as of Mar. 2026. GuruFocus rates NSE:AARTIDRUGS with a GF Score™ of 73/100 and a GF Value™ of ₹497.92 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Aarti Drugs's quarterly construction in progress declined from Sep. 2025 (₹1,791 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹2,138 Mil).

Aarti Drugs's annual construction in progress increased from Mar. 2024 (₹2,440 Mil) to Mar. 2025 (₹2,909 Mil) but then declined from Mar. 2025 (₹2,909 Mil) to Mar. 2026 (₹2,138 Mil).

Aarti Drugs Construction In Progress Historical Data

* Premium members only.

The historical data trend for Aarti Drugs's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarti Drugs Construction In Progress Chart

Aarti Drugs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,051.72 2,104.83 2,440.31 2,909.48 2,138.10

Aarti Drugs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,909.48 0.00 1,791.40 0.00 2,138.10
NSE:AARTIDRUGS
73GF Score
Aarti Drugs Ltd NSE:AARTIDRUGS
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aarti Drugs Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹2,138 Mil mean?
Aarti Drugs (NSE:AARTIDRUGS) has a Construction In Progress of ₹2,138 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Aarti Drugs and its competitors.
Is Aarti Drugs' Construction In Progress too high?
Aarti Drugs' current Construction In Progress is ₹2,138 Mil. Overall, Aarti Drugs has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aarti Drugs' Construction In Progress compare to ZTS and UTHR?
Aarti Drugs' Construction In Progress of ₹2,138 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Aarti Drugs and its competitors. Aarti Drugs's current Construction In Progress is ₹2,138 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aarti Drugs stock overvalued right now?
Based on GuruFocus' analysis, Aarti Drugs (NSE:AARTIDRUGS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹497.92, compared to a current price of ₹388.95 — trading 21.9% below its estimated fair value. The current Construction In Progress is ₹2,138 Mil. Aarti Drugs' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Aarti Drugs (NSE:AARTIDRUGS), the current Construction In Progress is ₹2,138 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aarti Drugs (NSE:AARTIDRUGS) Overvalued in 2026?

Based on GuruFocus' analysis, Aarti Drugs stock appears to be undervalued. The current stock price of ₹388.95 is trading 21.9% below its estimated GF Value™ of ₹497.92. GuruFocus considers Aarti Drugs to be Modestly Undervalued.

Key valuation signals for NSE:AARTIDRUGS:

  • Construction In Progress: ₹2,138 Mil
  • GF Value™: ₹497.92 vs. price of ₹388.95 (21.9% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the NSE:AARTIDRUGS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aarti Drugs Business Description

Other Exchanges 524348:India
Address Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.
73GF Score

Get the complete analysis for NSE:AARTIDRUGS

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹388.95
Price
₹497.92
GF Value